Research Archive — Page 55 of 131
-
May 17, 2022
Study identifies first cellular “chaperone” for zinc, sheds light on worldwide public health problem of zinc deficiency
A team led by Vanderbilt researchers has described and characterized the first zinc metallochaperone: a protein that puts zinc into other “client” proteins. -
May 12, 2022
Study sheds light on the dark side of obesity
Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity. -
May 12, 2022
VUMC-led study finds Moderna COVID vaccine safe and effective for children
-
May 10, 2022
Report lays out solution for pandemic patient privacy
Health information privacy experts at Vanderbilt University Medical Center, the University of Texas at Dallas and IBM have collaborated on a public case reporting framework keyed to the dynamics of pandemics. -
May 10, 2022
New study illustrates how much it would cost for cancer drugs covered under Medicare Part D
A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit. -
May 10, 2022
Nominations sought for the 2022 Vanderbilt Prize Student Scholar
Nominations for the 2022 Vanderbilt Prize Student Scholar are invited through May 27. -
May 10, 2022
Resistance to COVID-19 drug detected in lab study
Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.